Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Galipeau

Showing results (131-140 of 193) with videos related to

Pageof 20
Sort By:
Transplantation and Cellular Therapy|May 9, 2021
Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal CellsMolly Mercedes Ryan, Mihir Patel, Keenan Hogan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritisMoutih Rafei, Yamina A Berchiche, Elena Birman, et al.
Transplantation Direct|September 21, 2018
Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B CellsZijian Zhang, Nancy A Wilson, Raghavan Chinnadurai, et al.
Blood Advances|July 18, 2017
Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ primingRaghavan Chinnadurai, Devi Rajan, Spencer Ng, et al.
Cytotherapy|March 14, 2021
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predispositionJacques Galipeau, Mauro Krampera, Katarina Leblanc, et al.
Stem Cells Translational Medicine|April 19, 2022
Pancreatic Stellate Cells Prolong Ex Vivo Islet Viability and Function and Improve EngraftmentPradyut K Paul, Rahul Das, Travis J Drow, et al.
Cell Reports|March 1, 2018
Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix ApproachRaghavan Chinnadurai, Devi Rajan, Muna Qayed, et al.
Stem Cells (Dayton, Ohio)|April 30, 2019
Molecular Genetic and Immune Functional Responses Distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate CellsRaghavan Chinnadurai, Jenna Sands, Devi Rajan, et al.
Journal of Medical Virology|April 18, 2025
A Phase I Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against BK-Virus in Adult Kidney Transplant RecipientsLucy Ptak, Ross O Meyers, Olga Radko-Ganz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2011
Development and function of innate polyclonal TCRalphabeta+ CD8+ thymocytesMoutih Rafei, Marie-Pierre Hardy, Patrick Williams, et al.
Pageof 20

Showing results (131-140 of 193) with videos related to

Sort By:
Pageof 20
Transplantation and Cellular Therapy|May 9, 2021
Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal CellsMolly Mercedes Ryan, Mihir Patel, Keenan Hogan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 14, 2009
An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritisMoutih Rafei, Yamina A Berchiche, Elena Birman, et al.
Transplantation Direct|September 21, 2018
Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B CellsZijian Zhang, Nancy A Wilson, Raghavan Chinnadurai, et al.
Blood Advances|July 18, 2017
Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ primingRaghavan Chinnadurai, Devi Rajan, Spencer Ng, et al.
Cytotherapy|March 14, 2021
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predispositionJacques Galipeau, Mauro Krampera, Katarina Leblanc, et al.
Stem Cells Translational Medicine|April 19, 2022
Pancreatic Stellate Cells Prolong Ex Vivo Islet Viability and Function and Improve EngraftmentPradyut K Paul, Rahul Das, Travis J Drow, et al.
Cell Reports|March 1, 2018
Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix ApproachRaghavan Chinnadurai, Devi Rajan, Muna Qayed, et al.
Stem Cells (Dayton, Ohio)|April 30, 2019
Molecular Genetic and Immune Functional Responses Distinguish Bone Marrow Mesenchymal Stromal Cells from Hepatic Stellate CellsRaghavan Chinnadurai, Jenna Sands, Devi Rajan, et al.
Journal of Medical Virology|April 18, 2025
A Phase I Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against BK-Virus in Adult Kidney Transplant RecipientsLucy Ptak, Ross O Meyers, Olga Radko-Ganz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2011
Development and function of innate polyclonal TCRalphabeta+ CD8+ thymocytesMoutih Rafei, Marie-Pierre Hardy, Patrick Williams, et al.
Pageof 20